Cynata Therapeutics Limited

Cynata Therapeutics Limitedverified

CYYNF

Price:

$0.15

Market Cap:

$64.11M

Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. The company's lead therapeutic product candidate is CYP-001, which has completed Phase I clinical trial for the treatment of graft versus host disease. It also develops CYP-004, which is in Phase III clinical trial used for the treatment of osteoarthritis; and CYP-006TK, a novel polymercoated silicon wound dressing for diabetic wounds. In addition, the company develops products for the treatment of asthma, heart attack, coronary artery disease, acute respiratory distress syndrome, brain cancer, ...[Read more]

Industry

Biotechnology

IPO Date

2015-05-26

Stock Exchange

OTC

Ticker

CYYNF

The Enterprise Value as of December 2025 (TTM) for Cynata Therapeutics Limited (CYYNF) is 59.06M

According to Cynata Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 59.06M. This represents a change of 95.84% compared to the average of 30.16M of the last 4 quarters.

Cynata Therapeutics Limited (CYYNF) Historical Enterprise Value (quarterly & annually)

How has CYYNF Enterprise Value performed in the past?

The mean historical Enterprise Value of Cynata Therapeutics Limited over the last ten years is 47.72M. The current 59.06M Enterprise Value has changed 12.28% with respect to the historical average. Over the past ten years (40 quarters), CYYNF's Enterprise Value was at its highest in in the June 2019 quarter at 119.36M. The Enterprise Value was at its lowest in in the June 2007 quarter at -3248170.00.

Quarterly (TTM)
Annual

Average

47.72M

Median

38.82M

Minimum

1.97M

Maximum

118.29M

Cynata Therapeutics Limited (CYYNF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cynata Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.28%

Maximum Annual Enterprise Value = 118.29M

Minimum Annual Increase = -92.91%

Minimum Annual Enterprise Value = 1.97M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202525.69M-45.08%
202446.79M2.28%
20231.97M-92.91%
202227.78M-29.04%
202139.15M-21.86%
202050.10M-57.64%
2019118.29M6.19%
2018111.39M189.42%
201738.49M118.93%
201617.58M-65.80%

Cynata Therapeutics Limited (CYYNF) Average Enterprise Value

How has CYYNF Enterprise Value performed in the past?

The current Enterprise Value of Cynata Therapeutics Limited (CYYNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

24.82M

5-year avg

28.28M

10-year avg

47.72M

Cynata Therapeutics Limited (CYYNF) Enterprise Value vs. Peers

How is CYYNF’s Enterprise Value compared to its peers?

Cynata Therapeutics Limited’s Enterprise Value is less than MedMira Inc. (59.27M), greater than Sernova Corp. (47.11M), greater than Defence Therapeutics Inc. (48.57M), greater than Provectus Biopharmaceuticals, Inc. (33.76M), greater than Drug Free Solution, Inc. (476.40K), greater than Medical Developments International Limited (45.55M), greater than Novacyt S.A. (9.16M), greater than Oncotelic Therapeutics, Inc. (57.10M), greater than Vivos Inc. (30.94M), less than The Cannabist Company Holdings Inc. (446.01M),

Build a custom stock screener for Cynata Therapeutics Limited (CYYNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cynata Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cynata Therapeutics Limited (CYYNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cynata Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Cynata Therapeutics Limited's Enterprise Value?

What is the highest Enterprise Value for Cynata Therapeutics Limited (CYYNF)?

What is the 3-year average Enterprise Value for Cynata Therapeutics Limited (CYYNF)?

What is the 5-year average Enterprise Value for Cynata Therapeutics Limited (CYYNF)?

How does the current Enterprise Value for Cynata Therapeutics Limited (CYYNF) compare to its historical average?